Loss of taste and smell during treatment with topiramate

被引：10

作者：

Ghanizadeh, A. ^{[1
,2
]}

机构：

[1] Shiraz Univ Med Sci, Dept Psychiat, Res Ctr Psychiat Behav Sci, Hafez Hosp, Shiraz, Iran

[2] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Acad Child Psychiat Unit, Melbourne, Vic 3050, Australia

来源：

EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY | 2009年 / 14卷 / 2-3期

关键词：

Topiramate; taste; smell; sensory; epilepsy; WEIGHT-GAIN; HALLUCINATIONS; EPILEPSY;

D O I：

10.1007/BF03327811

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

Topiramate has already been suggested for treatment of olfactory hallucianation. This is a report of a three and a half-year-old boy with idiopathic generalized tonic colonic epilepsy. He had lost his ability to detect and recognize taste and odor during treatment with topiramate. Those abilities improved after discontinuation of topiramate. (Eating Weight Disord. 14: 037-038, 2009). (C) 2009, Editrice Kurtis

引用

收藏

页码：E137 / E138

页数：2

相关论文

共 8 条

[1] Topiramate in venlafaxine-induced visual hallucinations in an obese patient with a posterior cerebral artery infarction [J].

Anghelescu, I ;

Klawe, C ;

Himmerich, H ;

Szegedi, A .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (04) :462-464

[2]

Dursun SM, 2000, CAN J PSYCHIAT, V45, P198

[3] Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages [J].

Faught, E ;

Wilder, BJ ;

Ramsay, RE ;

Reife, RA ;

Kramer, LD ;

Pledger, GW ;

Karim, RM ;

Barr, A ;

Fischer, J ;

Bergen, D ;

Boor, D ;

Browne, T ;

Davenport, J ;

Dichter, M ;

Drake, M ;

Kuzniecky, R ;

Mamdani, M ;

McCutchen, C ;

Naritoku, D ;

Potolicchio, S ;

Ramani, V ;

Ramsay, R ;

Shinnar, S ;

So, E ;

Wilder, B .

NEUROLOGY, 1996, 46 (06) :1684-1690

[4] Treatment of olfactory hallucinations with topiramate [J].

Johnson, Joel ;

Bourgeois, James A. ;

Quanbeck, Cameron .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (03) :340-341

[5] Topiramate - A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy [J].

Langtry, HD ;

Gillis, JC ;

Davis, R .

DRUGS, 1997, 54 (05) :752-773

[6] Use of topiramate for glossodynia [J].

Siniscalchi, Antonio ;

Gallelli, Luca ;

Marigliano, Norma Maria ;

Orlando, Paola ;

De Sarro, Giovambattista .

PAIN MEDICINE, 2007, 8 (06) :531-534

[7] Topiramate treatment for SSRI-induced weight gain in anxiety disorders [J].

Van Ameringen, M ;

Mancini, C ;

Pipe, B ;

Campbell, M ;

Oakman, J .

JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (11) :981-984

[8]

Wu W. N., 1994, Pharmaceutical Research (New York), V11, pS336